Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001071786 | SCV001237107 | pathogenic | Isovaleryl-CoA dehydrogenase deficiency | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 292 of the IVD protein (p.Gly292Arg). This variant is present in population databases (rs568885234, gnomAD 0.004%). This missense change has been observed in individual(s) with isovaleric acidemia (PMID: 31707166, 35095998; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.865G > A p.G289R. ClinVar contains an entry for this variant (Variation ID: 864566). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001071786 | SCV004198010 | likely pathogenic | Isovaleryl-CoA dehydrogenase deficiency | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001071786 | SCV001461295 | uncertain significance | Isovaleryl-CoA dehydrogenase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |